Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation

Annals of Surgery

Volumn 259, Issue 5, 2014, Pages 888-893

  Pilch, Nicole A ^a   Taber, David J ^b   Moussa, Omar ^b   Thomas, Beje ^a   Denmark, Signe ^b   Meadows, Holly B ^a   McGillicuddy, John W ^b   Srinivas, Titte R ^a   Baliga, Prabhakar K ^b   Chavin, Kenneth D ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

induction; kidney transplantation; panel reactive antibody; race; tacrolimus

Indexed keywords

BASILIXIMAB; CORTICOSTEROID DERIVATIVE; CREATININE; DACLIZUMAB; LEUKOCYTE ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANEL REACTIVE ANTIBODY; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BACTERIAL KIDNEY DISEASE; CHRONIC GRAFT REJECTION; COLD ISCHEMIA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DELAYED GRAFT FUNCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT SURVIVAL; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LENGTH OF STAY; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTILYMPHOCYTE SERUM; BIOPSY; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INDUCTION CHEMOTHERAPY; KIDNEY TRANSPLANTATION; MIDDLE AGED; PROSPECTIVE STUDIES; RABBITS; RECEPTORS, INTERLEUKIN-2; RECOMBINANT FUSION PROTEINS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84899483553     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000496     Document Type: Article

References (23)

1. Mourad G, Rostaing L, Legendre C, et al. Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids. Transplantation. 2004; 78: 584-590.
2. Sheashaa HA, Bakr MA, IsmailAM, et al. Long-termevaluation of basiliximab induction therapy in live donor kidney transplantation: a five-year prospective randomized study. Am J Nephrol. 2005; 25: 221-225.
3. Nashan B. Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens: a comparative review. Biodrugs. 2005; 19: 39-46.
4. Bunnapradist S, Takemoto SK. Multivariate analysis of antibody induction therapy and their associated outcomes in deceased donor transplants. Transplant Proc. 2005; 37: 889-891.
5. Young CJ, Gaston RS. Renal transplantation in black Americans. N Engl J Med. 2000; 343: 1545-1552.
6. Weimert NA, Alloway RR. Renal transplantation in high-risk patients. Drugs. 2007; 67: 1603-1627.
7. Szczech LA, Berlin JA, Aradhye S, et al. Effect of anti-lymphocyte induction therapy on renal allograft survival: a meta-analysis. J Am Soc Nephrol. 1997; 8: 1771-1777.
8. Szczech LA, Berlin JA, Feldman HI. The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data. Anti-Lymphocyte Antibody Induction Therapy Study Group. Ann Intern Med. 1998; 128: 817-826.
9. Bumgardner GL, Hardie I, Johnson RW, et al. Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation. Transplantation. 2001; 72: 839-845.
10. Sheashaa HA, Bakr MA, IsmailAM, et al. Long-termevaluation of basiliximab induction therapy in live donor kidney transplantation: a five-year prospective randomized study. Am J Neph. 2005; 23: 221-225.
11. Sheashaa HA, Bakr MA, Ismail AM, et al. Basiliximab reduces the incidence of acute cellular rejection in live-related-donor kidney transplantation: a threeyear prospective randomized trial. J Nephrol. 2003; 16: 393-398.
12. Hirsch HH, Vincenti F, Friman S, et al. Polyomavirus BKreplication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant. 2013; 13: 136-145.
13. Nankivell BJ, Kuypers DR. Diagnosis and prevention of chronic kidney allograft loss. Lancet. 2011; 378: 1428-1437.
14. Thymoglobulin [Package Insert]. Cambridge M: Genzyme Corporation; 2008.
15. Racusen LC, Solez K, Colvin RB, et al. The Banff97 working classification of renal allograft pathology. Kidney Int. 1999; 55: 713-723.
16. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145: 247-254.
17. Lebranchu Y, Bridoux F, Büchler M, et al. Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Transplant. 2002; 2: 48-56.
18. Gaston RS, Hudson SL, Deierhoi MH, et al. Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression. Transplantation. 1992; 53: 103-109.
19. Gaston RS, Shroyer TW, Hudson SL, et al. Renal retransplantation: the role of race, quadruple immunosuppression, and the flow cytometry cross-match. Transplantation. 1994; 57: 47-54.
20. Brennan DC, Daller JA, Lake KD, et al. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med. 2006; 355: 1967-1977.
21. Sollinger H, Kaplan B, Pescovitz MD, et al. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection. Transplantation. 2001; 72: 1915-1919.
22. Buettner M, Xu H, Böhme R, et al. Predominance of Th2 cells and plasma cells in polyomavirus nephropathy: a role for humoral immunity? Hum Pathol. 2012; 43: 1453-1462.
23. Zeigler ST, Gaston RS, Rhynes VK, et al. Renal transplantation in African- American recipients: three decades at a single center. Transplant Proc 1997; 29: 3726-3728.